Skip to main content
Category

BioTalk with Rich Bendis Podcast

Troy and Rich

Troy A LeMaile-Stovall, Chief Executive Officer and Executive Director of TEDCO Guests on BioTalk

By BioTalk with Rich Bendis Podcast

Troy and RichTroy A LeMaile-Stovall, CEO and Executive Director of TEDCO, joins Rich Bendis BioTalk to discuss his background, the local ecosystem, and their vision for the future here in Maryland

Listen now via Apple http://apple.co/3tMsGQ4 , Google http://bit.ly/372QPs5 , http://spoti.fi/3tV2vXI , and TuneIn http://bit.ly/3aOuuzC.

Read More
BrettAndRich

Brett Malone, Ph.D., President and CEO of the Virginia Tech Corporate Research Center, Guests on BioTalk

By BioTalk with Rich Bendis Podcast

BrettAndRichVirginia Tech Corporate Research Center President and CEO, Brett Malone, Ph.D., joins Rich Bendis on BioTalk to discuss regional expansion plans, strategic partnerships, and success stories.

Listen now via Apple http://apple.co/3cPyW3t, Google http://bit.ly/3a1kP9m, Spotify http://spoti.fi/3cSwQ2Q, and TuneIn http://bit.ly/3a1kYJW

Read More
VA Biotalk

New “Virginia Bio-Connect” Statewide Consortium and Scale-Up Initiative Featured on BioTalk

By BioTalk with Rich Bendis Podcast

VA BiotalkAmy Adams with George Mason University. Nikki Hastings with CvilleBioHub, and John Newby with Virginia Bio join Rich Bendis to discuss the new “Virginia Bio-Connect” statewide consortium and scale-Up initiative.

Listen now via Apple http://apple.co/39ZDl0M, Google http://bit.ly/3iRzmHO, Spotify https://spoti.fi/2MqHTVJ, and TuneIn http://bit.ly/2Yelr58. #innovation #biotalk #university #healthcare #digitalhealth #healthtech #research #biotech

Read More
RonANDRich

United States Pharmacopeia CEO Ronald T. Piervincenzi, Ph.D. Joins Rich Bendis on the BioTalk Podcast

By BioTalk with Rich Bendis Podcast

RonANDRichRonald T. Piervincenzi, Ph.D., Chief Executive Officer, United States Pharmacopeia virtually sits down with Rich Bendis to discuss the over 200 year old Organization, the services they offer, and their goals for the future.

Listen now on Google http://bit.ly/2NjX8As, Apple http://apple.co/3irukRQ, Spotify http://spoti.fi/35UfM8B, and TuneIn http://bit.ly/2XRFEgD.

Read More
ChrisKeithRich

Chris Mathia, Chief Executive Officer, Innara Health, and Keith Molzer, Managing Partner, Flyover Capital, join Rich Bendis from Kansas City on BioTalk

By BioTalk with Rich Bendis Podcast

ChrisKeithRichWhile home in Kansas City for the season, BioTalk host Rich Bendis virtually sits down two local business leaders. Innar Health CEO, Chris Mathia, and Flyover Capital Managing Partner, Keith Molzer chat about the opportunities and challenges of BioHealth and Fund-Raising in Middle American.

Listen now via Google http://bit.ly/39ikNss, Apple http://apple.co/3shRRtk, Spotify http://spoti.fi/39ocgUz, and TuneIn http://bit.ly/2XvT0za.

Read More
James Crowe AND Rich Bendis

Dr. James Crowe, Director, Vanderbilt Vaccine Center, Guests on BioTalk

By BioTalk with Rich Bendis Podcast

James Crowe AND Rich Bendis BioTalk Media Award-Winning Podcast BioTalk Welcomes Dr. James Crowe, Director, Vanderbilt Vaccine Center, Professor, Pediatrics and Pathology, Microbiology and Immunology, Ann Scott Carell Chair and Founder of ID Biologics.

Listen now on Apple http://apple.co/34u0kz6, Google http://bit.ly/38jfE2I, Spotify http://spoti.fi/3pddVme, and TuneIn http://bit.ly/37D2M8z.

His laboratory has a broad portfolio of work in the area of viral immunology and antibody sciences, with the goal to discover mechanisms of immunity important to developing new therapeutics and vaccines.

Read More
StuANDRich

Connected DMV President & CEO Stu Solomon joins Rich Bendis on BioTalk

By BioTalk with Rich Bendis Podcast

StuANDRichStu Solomon, President & CEO, Connected DMV joins BioTalk to discuss formation of the Strategic Renewal Task Force, their Covid-19 Pandemic Pivot, the Global Pandemic Prevention and Bioterrorism Center, and much more.

Listen now on Apple https://apple.co/3gqmJlB, Google https://bit.ly/3mVtled, Spotify https://spoti.fi/3mO0j05, and TuneIn https://bit.ly/37FMf2t.

Click here to read the transcript.

Carol Nacy and Rich Bendis

Dr. Carol Nacy, CEO of Sequella Incorporated, joins BioTalk to discuss her career, the evolution of their science, and vision for the future.

By BioTalk with Rich Bendis Podcast

Carol Nacy and Rich BendisListen now via Apple https://apple.co/374aOFI, Google https://bit.ly/3pTGqqj, Spotify https://bit.ly/3nIl7WO, and TuneIn https://bit.ly/3nIl7WO

Dr. Nacy co-founded our Sequella in 1997 and has served as our CEO and Chairman of the Board since 1999. Prior to Sequella, Dr. Nacy served during 1997 and 1998 as Chief Scientific Officer (CSO) for Anergen, Inc., a California company acquired by Corixa Corporation in December 1998. From 1993 through 1997, Dr. Nacy was Executive Vice President and CSO at EntreMed, Inc. and participated in its successful initial public offering in June 1996. Previously, Dr. Nacy was Career Scientist (GS-15) at the Walter Reed Army Institute of Research, Washington, DC. Dr. Nacy currently serves on the board of directors of companies and non-profit agencies.

Click here for the Transcript

Praduman Jain and Rich Bendis

Praduman (PJ) Jain, CEO and Founder of Vibrent Health, Joins BioTalk to Discuss Entrepreneurism, Funding, and Health Technology in the BioHealth Capital Region

By BioTalk with Rich Bendis Podcast

Praduman Jain and Rich BendisListen now on Apple https://apple.co/36iBbrp, Google https://bit.ly/32rZdiq, Spotify https://spoti.fi/2U7HEzs, and TuneIn https://bit.ly/3eOtb5i.

Praduman Jain, known to colleagues as “PJ,” is CEO and Founder of Vibrent Health and the Principal Investigator of the Participant Technology Systems Center of the National Institutes of Health Precision Medicine Initiative, the All of Us Research Program, for which the PTSC received a $75 million grant in 2017 and an additional award in 2020 with initial first-year funding of $39 million to build a national platform for health research and health management insights for 1 million people across the U.S. for at least 10 years.  Jain is also the Chair of the Security Board of the Committee on Access, Privacy & Security for the NIH All of Us Research Program; a member of the Roundtable on Genomics and Precision Health at the National Academies of Sciences, Engineering, and Medicine; an invited external expert for eMERGE & Beyond, The Future of Electronic Medical Records and Genomics program of the Division of Genomic Medicine, National Human Genome Research Institute; and an external advisory board member for iTHRIVE – a Virginia Clinical and Translational Science Award.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.